Electrocore ECOR 深 沪
等待开盘 11-06 09:30:00 美东时间
8.80
+0.400
+4.76%
华盛通- 最 高8.9999
- 今 开8.12
- 成交量 18.54万股
- 最 低 7.895
- 昨 收 8.40
- 总市值 7933.98万
- 52周最高 12.70
- 市盈率 静 --
- 换手率 2.06%
- 52周最低 4.41
- 委 比 -97.06%
- 总股本 901.59万
- 历史最高 303.75
- 量 比 1.66
- 振 幅 13.15%
- 历史最低 2.925
- 每 手 1
- 风险率 1.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
electroCore, Inc. announced that its management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026, in New York City. Joshua Lev, Co-CEO, President, and CFO, will present at the conference and host investor meetings. Interested investors should contact their Canaccord Genuity sales representative. electroCore specializes in non-invasive bioelectronic technologies, offering produ...
11-05 13:00
electroCore Sees FY 2027 revenue guidance of 30% to 40% YoY
electroCore (NASDAQ:ECOR) Sees FY 2027 revenue guidance of 30% to 40% YoY
11-05 06:04
electroCore Raises FY2026 Sales Guidance from $41.600M to $41.642M vs $41.915M Est
electroCore (NASDAQ:ECOR) raises FY2026 sales outlook from $41.600 million to $41.642 million vs $41.915 million estimate.
11-05 05:38
Electrocore Llc收跌4.79%，成交额70.84万美元
11月3日，Electrocore Llc（ECOR）收跌4.79%，报7.16美元，成交额70.84万美元，市值6455.37万美元。 行情数据 • 开盘价...
11-03 08:14
electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026
electroCore, Inc. will report its Q3 2026 financial results on November 4, 2026, after market close. Management will host a conference call and webcast at 4:30 PM EST that day to discuss the results. Participants can join via telephone (877-407-8835 / +1 201-689-8779) or webcast using the provided link. A replay will be available on the company’s investor website. The company specializes in bioelectronic technologies for health and wellness, with...
10-29 12:00
electroCore Submits Premarket Notification Seeking Clearance From FDA For Its Quell Wearable Neuromodulation Platform To Treat Chronic Chemotherapy-Induced Peripheral Neuropathy
electroCore, Inc. (NASDAQ:ECOR), ("electroCore" or the "Company"), a bioelectronic technology company, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance for its Quell® wearable neuromodulation platform ("Quel...
10-28 20:03
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
A controlled study involving 50 healthy adults conducted by the United States Air Force Research Laboratory (AFRL) using electroCore's tcVNS technology suggests that transcutaneous cervical vagus nerve stimulation can enhance complex visual skill learning. Results indicate accelerated learning, improved executive efficiency, and stronger behavioral coordination during a visual pattern-recognition task. The study also shows reduced long-term deman...
10-27 12:00
Electrocore Llc收跌4.86%，成交额94.89万美元
10月24日，Electrocore Llc（ECOR）收跌4.86%，报7.05美元，成交额94.89万美元，市值6356.2万美元。 行情数据 • 开盘价...
10-24 07:19
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced its participation in the Planet MicroCap Toronto 2026 conference. Joshua Lev, Co-CEO, President, and CFO, will present on October 28 at 9:30 am ET and host investor meetings. The event takes place at Arcadian Court & Loft, 401 Bay St, Toronto, ON, M5H 2Y4. A webcast is available, and investors can register for meetings at planetmicrocap.com. electroCore spe...
10-21 12:00
Electrocore Llc收跌5.99%，成交额109.42万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:17
